Atlas FDA

Prospera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management

FDA premarket approval P210037/S011 · decided 2025-06-25

Approval details

PMA number
P210037
Supplement
S011
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Prospera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Biotronik Nro, Inc.
Date received
2025-04-04
Decision date
2025-06-25
Days to decision
82 days
Decision code
APPR
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Lake Oswego, OR
Statement
approval for changes made to the Prospera SCS System embedded software (implant software [ISW]) and Neuro Service Center (NSC). Specifically, the Prospera SCS System embedded software (ISW) was updated to version 1.0.3, which included changes to the lead impedance measurements algorithm to provide more information during intraoperative testing and improve the accuracy of calculation of resistive measurements. The NSC was updated to version 1.6.3, which included changes to allow magnetic resonanc

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.